U.S. Court in Massachusetts Allows Drug Manufacturer’s Medicare Part D Coverage Dispute to Proceed
- July 30, 2021
The U.S. District Court for the District of Massachusetts allowed a drug manufacturer to proceed with its lawsuit alleging the Centers for Medicare & Medicaid Services (CMS) improperly eliminated Medicare Part D coverage for one of the approved uses of its drug to treat anemia.
ARTICLE TAGS
You must be logged in to access this content.